Chronic Hepatitis C Summary

Networked: 9520 relevant articles (924 outcomes, 1539 trials/studies) for this Disease

Key Drugs and Agents for Chronic Hepatitis C

1. Interferons : 438 outcomes 536 studies in 3605 results : IBA
   
2. Ribavirin (Virazole) : 385 outcomes 540 studies in 3023 results : FDA 16 Generic
   
3. Interferon-alpha (Interferon Alfa) : 188 outcomes 220 studies in 1644 results : FDA 2
   
4. RNA (Ribonucleic Acid) : 51 outcomes 84 studies in 729 results : IBA
   
5. telaprevir : 27 outcomes 49 studies in 221 results : IBA
   
6. Amantadine (Aman) : 27 outcomes 35 studies in 97 results : FDA 20 Generic
   
7. Alanine Transaminase (SGPT) : 14 outcomes 31 studies in 235 results : IBA
   
8. Interferon Alfa-2b (Interferon Alfa 2b) : 14 outcomes 26 studies in 119 results : FDA 2
   
9. Interferon-beta : 14 outcomes 8 studies in 70 results : IBA
   
10. N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide : 13 outcomes 28 studies in 122 results : IBA
    

Diseases Related to Chronic Hepatitis C

1. Infection
2. Fibrosis (Cirrhosis)
3. Hepatocellular Carcinoma (Hepatoma)
4. Hepatitis C
5. Liver Diseases (Liver Disease)

Key Therapies for Chronic Hepatitis C

1. Retreatment : 25 outcomes 15 studies in 117 results
   
2. Renal Dialysis (Hemodialysis) : 9 outcomes 22 studies in 104 results
   
3. Aftercare (After-Treatment) : 8 outcomes 16 studies in 92 results
   
4. Transplants (Transplant) : 5 outcomes 9 studies in 124 results
   
5. Transplantation (Transplant Recipients) : 5 outcomes 6 studies in 83 results